Latest Breaking News On - Kristen harrington smith - Page 1 : comparemela.com

ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript

AbbVie to acquire ADC manufacturer ImmunoGen for $10.1B in oncology play

The ImmunoGen deal, which is expected to close in the middle of 2024, is also estimated to be accretive to AbbVie’s diluted earnings per share beginning in 2027.

ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update

1Q 2023 ZYNLONTA®1 net sales increased 15% and operating expenses decreased 19% year-over-year2; FY 2023 guidance reaffirmed for ZYNLONTA double-digit net sales growth and reduction in operating. | May 9, 2023

ADC Therapeutics SA: ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update

1Q 2023 ZYNLONTA®1 net sales increased 15% and operating expenses decreased 19% year-over-year2; FY 2023 guidance reaffirmed for ZYNLONTA double-digit net sales growth and reduction in operating expenses

ADC Therapeutics SA (NYSE:ADCT) Q4 2022 Earnings Call Transcript

Operator: Welcome to the ADC Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Andrew, and I ll be your operator for today s call.